A phase I/II trial of docetaxel (D) and oxaliplatin (O) in patients with advanced gastric cancer (AGC)

被引：0
|
作者：
Park, Y. [1 ]
Kim, K. [1 ]
Choi, M. [1 ]
Hong, J. [1 ]
Lee, E. [1 ]
Park, M. [1 ]
Kim, H. [1 ]
Lee, Y. [1 ]
Park, J. [1 ]
Lim, H. [1 ]
Kang, W. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15615
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kim, Kyoung Ha
    Park, Young Suk
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 347 - 353
  • [2] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kyoung Ha Kim
    Young Suk Park
    Myung Hee Chang
    Hyo Song Kim
    Hyun Jung Jun
    Jieun Uhm
    Seong Yoon Yi
    Do Hyoung Lim
    Sang Hoon Ji
    Min Jae Park
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 347 - 353
  • [3] PHASE I AND PHARMACOLOGIC STUDY OF DOCETAXEL (D), OXALIPLATIN(O), CAPECITABINE (C) FOR UNTREATED PATIENTS (PTS) AFFECTED BY ADVANCED GASTRIC CANCER (AGC)
    Buonadonna, A.
    Miolo, G.
    Corona, G.
    Elia, C.
    Toffoli, G.
    Turchet, E.
    Tumolo, S.
    Lo Re, G.
    Frustaci, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 261 - 261
  • [4] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
  • [5] Phase II trial of miniDOX (reduced dose docetaxel–oxaliplatin–capecitabine) in “suboptimal” patients with advanced gastric cancer (AGC). TTD 08-02
    F. Rivera
    B. Massutí
    M. Salcedo
    J. Sastre
    J. Martínez Galán
    M. Valladares-Ayerbes
    R. Serrano
    Mª. L. García de Paredes
    J. L. Manzano
    M. Galán
    M. Alsina
    A. L. Yuste Izquierdo
    C. López
    E. Díaz-Rubio
    V. Conde
    M. Reboredo
    Mª. T. Cano
    V. Pachón
    E. Aranda
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 319 - 324
  • [6] Phase I/II trial of docetaxel plus oxaliplatin and 5-fluorouracil (D-FOX) in patients with untreated, advanced gastric or gastroesophageal cancer
    Ajani, J. A.
    Phan, A.
    Ho, L.
    Tetzlaff, E. D.
    Baker, J.
    Wei, Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Phase I/II docetaxel, oxaliplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Kim, Sung Rok
    Park, Sung-En
    Yuh, Young Jin
    Sohn, Byeong Seok
    Lee, Hye Ran
    Song, Hong-Suk
    Lee, Kyung-Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [8] Phase II trial of oxaliplatin plus capecitabine as first-line treatment in patients with advanced gastric cancer (AGC)
    Palumbo, R.
    Bernardo, A.
    Strada, M. R.
    Poggi, G.
    Teragni, C.
    Delmonte, A.
    Frascaroli, M.
    Jedrychowska, I
    Canto, A. M.
    Bernardo, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI51 - XI52
  • [9] Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients
    Frustaci, Sergio
    Buonadonna, Angela
    Turchet, Elisa
    Corona, Giuseppe
    Tabaro, Gianna
    Miolo, GianMaria
    Torrisi, Elena
    Lo Re, Giovanni
    Tumolo, Salvatore
    Toffoli, Giuseppe
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 510 - 516
  • [10] Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients
    Sergio Frustaci
    Angela Buonadonna
    Elisa Turchet
    Giuseppe Corona
    Gianna Tabaro
    GianMaria Miolo
    Elena Torrisi
    Giovanni Lo Re
    Salvatore Tumolo
    Giuseppe Toffoli
    International Journal of Clinical Oncology, 2013, 18 : 510 - 516
12345